Stockreport

eFFECTOR Therapeutics Announces Closing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]

eFFECTOR Therapeutics, Inc.  (EFTR) 
PDF in the development of selective translation regulator inhibitors (“STRIs”) for the treatment of cancer, today announced that it has closed its previously announced regis [Read more]